Sign Up to like & get
recommendations!
0
Published in 2020 at "Biological Psychiatry"
DOI: 10.1016/j.biopsych.2020.02.014
Abstract: BACKGROUND Maintenance treatment with opioid agonists (buprenorphine, methadone) is effective for opioid addiction but does not eliminate opioid use in all patients. We modeled maintenance treatment in rats that self-administered the prescription opioid oxycodone. The…
read more here.
Keywords:
oxycodone seeking;
protein biased;
maintenance;
biased opioid ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Neuropharmacology"
DOI: 10.1016/j.neuropharm.2019.01.020
Abstract: &NA; One emerging strategy to address the opioid crisis is the development of mu opioid receptor (MOR) ligands that preferentially signal the G‐protein vs. &bgr;‐arrestin pathway. The present study compared the relative potency and effectiveness…
read more here.
Keywords:
tail withdrawal;
protein biased;
stimulus effects;
mor ... See more keywords
Sign Up to like & get
recommendations!
3
Published in 2022 at "Pharmacological research"
DOI: 10.1016/j.phrs.2022.106223
Abstract: Dopamine D3 receptors (D3R) have a causal role in neurological and psychiatric disorders. We have developed a novel class of G-protein biased (GPB) signaling D3R agonists with minimal β-arrestin2 (βarr2) recruitment and demonstrated efficacy in…
read more here.
Keywords:
activation;
protein biased;
phosphorylation;
gpb agonists ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of medicinal chemistry"
DOI: 10.1021/acs.jmedchem.1c00110
Abstract: There has been significant attention concerning the biased agonism of G protein-coupled receptors (GPCRs), and it has resulted in various pharmacological benefits. 5-HT7R belongs to a GPCR, and it is a promising pharmaceutical target for…
read more here.
Keywords:
protein;
biased ligands;
ligands ht7r;
discovery protein ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Bioengineered"
DOI: 10.1080/21655979.2022.2031418
Abstract: ABSTRACT Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are considered as effective treatments for type 2 diabetes. Here, we describe the in vitro characteristics and in vivo anti-diabetic efficacies of a novel GLP-1RA, termed SM102. The in…
read more here.
Keywords:
eye syndrome;
dry eye;
glucagon like;
potency driven ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "British Journal of Clinical Pharmacology"
DOI: 10.1111/bcp.14632
Abstract: SAR247799 is a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 (S1P1) agonist designed to activate endothelial S1P1 and provide endothelial‐protective properties, while limiting S1P1 desensitization and consequent lymphocyte‐count reduction associated with higher doses. The aim was to show…
read more here.
Keywords:
endothelial protective;
biased sphingosine;
sar247799;
sphingosine phosphate ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "British Journal of Pharmacology"
DOI: 10.1111/bph.14702
Abstract: Opioids remain the most efficient medications against severe pain; they act on receptors that couple to heterotrimeric G‐proteins in the Gαi/o family. Opioids exert many of their acute effects through modulating ion channels via Gβγ…
read more here.
Keywords:
ion channels;
pzm21 trv130;
agents pzm21;
biased agents ... See more keywords